GlobeNewswire

MediaPlatform at ISE 2018 to Showcase Award-Winning Enterprise Streaming Platform

Del

Leader in Gartner Magic Quadrant to Demonstrate Webcasting and Video Content Management Capabilities

 

AMSTERDAM, The Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Integrated Systems Europe - 6-9 February 2018 - MediaPlatform (www.mediaplatform.com), the leading enterprise video platform enabling live webcasting and on-demand streaming, is pleased to announce its presence at Integrated Systems Europe (ISE), the world's largest audiovisual and system integrations conference.

MediaPlatform, a Leader in the Gartner Magic Quadrant and Forrester Wave, has a rising global presence, which has grown significantly in the past year, with noteworthy customer acquisitions and a rising sales presence in Europe and the EMEA region.

Among its growing customer base, MediaPlatform has acquired the business of Fortune 500 companies across the United States in the fields of research, finance and technology, as well as cementing its presence in Europe with a multi-billion-dollar technology manufacturer based in Switzerland. 

MediaPlatform To Showcase Enterprise Streaming and Unified Communication  Integrations

MediaPlatform will be showcasing its enterprise streaming platform, as well as its integration options for unified communications at ISE Amsterdam. Through seamless integrations with videoconferencing solutions, web conferencing tools and enterprise social platforms, MediaPlatform helps organizations create a single environment for creating internal corporate broadcasts, distributing on-demand media and managing enterprise video assets.

"It's exciting to share our award-winning platform and enterprise webcasting capabilities with the attendees of ISE," said Mike Newman, CEO, MediaPlatform. "It's a tremendous show and attendee base and, with all of the momentum and growth in enterprise webcasting and unified communications, it seems like the perfect time to increase our presence in the European market."

MediaPlatform To Showcase Agnostic Video Delivery for Enterprise Webcasting

MediaPlatform will also be providing demos of its new Unified Video Player for agnostic delivery of enterprise webcasting. The company's video player is the next step in the evolution of a product designed to meet the needs of organizations with plans to transition away from Flash, while remaining the most secure option for companies significantly invested in IP multicasting.

"I speak for everyone at MediaPlatform in saying how excited we are to be able to share our story around enterprise streaming at ISE. This show always brings together a great mix of cutting-edge solutions, products and technologies," said Jared Hawkins, VP Product, MediaPlatform.

In addition to demoing its award-winning enterprise video platform, MediaPlatform will be showcasing its integrations with proven technology providers to improve video content delivery and management. These include:

Skype for Business
The MediaPlatform integration with Skype for Business helps deliver interactive all-hands broadcasts to audiences of well over 10,000 live concurrent viewers and manage recordings in a secure and searchable enterprise video portal.

Polycom
MediaPlatform's interoperability with Polycom enables webcasting of video sessions to audiences of unlimited size, and seamless publishing of recordings to a secure video portal.

Cisco
For organizations leveraging the Cisco TelePresence Content Server (TCS), MediaPlatform enables video from Cisco-powered videoconferences to automatically stream to a live webcast, be archived, and be published to a secure video portal.

Pexip
MediaPlatform has partnered with Pexip to integrate the WebCaster live streaming solution with the Pexip Infinity platform to enable large-scale webcasting of virtual meetings.

WebEx
MediaPlatform's Cisco WebEx integrations provide organizations with a central and searchable repository for web conference recordings, online meetings and videoconferences.

MediaPlatform will be exhibiting in Hall 14 at Booth #14-K165 from 6-9 February 2018 at ISE Europe.

For more information, attendees can schedule a meeting to demo MediaPlatform's award-winning enterprise video solutions at ISE Europe here.

About MediaPlatform
MediaPlatform is a leading enterprise video platform enabling large-scale live streaming and on-demand video for executive messaging, e-learning, and collaboration. MediaPlatform provides a comprehensive set of products and services to help organizations leverage the power of video to improve employee engagement and enhance productivity. Organizations leveraging MediaPlatform's suite of products and services include Abbott Laboratories, Adobe, EY, Northwestern Mutual and Sprint.

www.mediaplatform.com

Media Contact:
Barry Canty
VP Marketing
MediaPlatform
bcanty@mediaplatform.com
(310) 909-8410




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MediaPlatform, Inc. via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

WillScot to Participate at the Barclays Industrial Select Conference16.1.2019 21:00Pressemelding

BALTIMORE, Jan. 16, 2019 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”)(NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Brad Soultz, President and Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will present at the Barclays Industrial Select Conference at the Loews Miami Beach Hotel in Miami, Florida, on Wednesday, Feb. 20, 2019. The presentation will take place at 10:20 a.m. EST. About Williams Scotsman Headquartered in Baltimore, Maryland, WillScot Corporation is the public holding company for the WillScot family of companies in the United States, Canada and Mexico. WillScot Corporation trades on the NASDAQ stock exchange under the ticker symbol “WSC.” WillScot is the specialty rental services market leader providing innovative modular space and portable storage solutions across North America. It is the modular space supplier of choice for t

CCI has been retained by Waterloo Brewing to obtain Cannabis Licence16.1.2019 16:00Pressemelding

TORONTO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Cannabis Compliance Inc., (CCI) of Toronto, Ontario is pleased to announce they have partnered with Waterloo Brewing to help them obtain their Research and standard Processing Licence to develop cannabis-infused beverages. “CCI is working with Waterloo Brewing on the early stages of the application process and we are confident that we will help them achieve their desired licenses in time to be an active player in this growing sector of the cannabis industry”, said Brian Wagner, CEO and Founder, Cannabis Compliance Inc. “We are here to guide our clients through the early stages of the licensing process and for the many Health Canada requirements thereafter.” CCI offers end to end business solutions for cannabis companies large and small. Our team brings with them years of experience in the quality, regulatory, security and cultivation sectors, and supports manufacturers and retailers through regulatory challenges. As the world’s largest and mos

Aryaka Announces Expansion of Senior Leadership Team with New Chief Revenue Officer, Chief Transformation Officer and Chief Marketing Officer16.1.2019 15:00Pressemelding

Karen Freitag, Michelle Owczarzak, & Shashi Kiran join Aryaka to address significant growth and assist global enterprises in adopting managed connectivity as-a-service SAN MATEO, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Aryaka®, announced today the appointment of several new executive hires to the company’s leadership team, including Karen Freitag (Chief Revenue Officer), Michelle Owczarzak (Chief Transformation Officer), and Shashi Kiran (Chief Marketing Officer). “Connectivity is the lifeblood of the global enterprise and Aryaka is the industry benchmark for secure managed connectivity worldwide. We are excited to have experienced industry veterans join our robust executive leadership team and continue to help build upon the immense success and growth that Aryaka has seen in recent years,” said Matt Carter, CEO of Aryaka. “As our customers expand globally, embrace SD-WAN, or move to the cloud, we’re becoming the de facto choice for their needs to make this happen better, faster, che

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors16.1.2019 07:00Pressemelding

Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors LAUSANNE, Switzerland, Jan. 16, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been dosed in its Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumor activity of ADCT-601 in patients with selected solid tumors that are locally advanced or metastatic. ADCT-601 is an ADC composed of a humanized monoclonal antibody against human AXL, conjugated using GlycoConnect™ site specific conjugation technology to a pyrrolobenzodiazepine (PBD) dimer toxin. In preclinical studies, ADCT-601 demonstrated potent and specific in vitro and in vivo anti-tumor activity in multiple cancer-derived models with different levels of AXL expression, and was stable and well tolerated

GSA Europe’s Managing Director Elected Co-lead of CEN’s TC456 Committee15.1.2019 21:12Pressemelding

SAN GWANN, Malta, Jan. 15, 2019 (GLOBE NEWSWIRE) -- GSA Europe’s Managing Director Mark Pace has been elected by the Comité Européen de Normalisation (CEN) to lead the creation of a European Union online gaming reporting standard. CEN has established Technical Committee 456 to create this standard in support of online gambling supervision. GSA Europe joined Technical Committee 456 as a Liaison Organization in 2017. The Technical Committee’s mandate from the European Commission is directly aligned with work that GSA Europe has already started, namely, to create a single standard set of data elements and single standard way in which data is provided by online gambling providers to EU Member State regulatory authorities. In addition to joining and now leading the Technical Committee’s work, GSA Europe also donated their draft Regulatory Data Set and Regulatory Reporting Interface to CEN seeking to help jump-start the Committee’s work. “Joining CEN’s TC456 as a Liaison Organization, and no

Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study15.1.2019 15:00Pressemelding

OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River Laboratories, evaluating the efficacy of OB-002O (5P12-RANTES) in colorectal cancer. BALB/c mice were inoculated subcutaneously with the CT-26 colorectal cancer cell line. Three days after inoculation intraperitoneal treatment was started with OB-002O, a murine anti-PD-1 antibody, OB-002 + anti-PD-1, or saline placebo. Treatment was given daily or every third day. Treatment with OB-0020 alone led to statistically significant delayed tumor growth at multiple time-points. An even more profound effect on the decrease in mean tumor volume was observed in combination cohort where animals received both, OB-0020 and the anti-PD-1 antibody (p>0.05). “There is growing awareness of the role of CCR5 antagonism as an important component of cancer immunotherapy. OB-002O is an extremely potent CCR5 antagonist